Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fake-Fast diet may soothe gum treatment side effects

NCT ID NCT06074861

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special 5-day fasting-mimicking diet (plant-based soups, bars, and drinks) could reduce inflammation after deep cleaning for advanced gum disease. Twenty-eight adults with stage III-IV periodontitis were randomly assigned to either follow the diet or eat normally. Researchers measured inflammation markers in blood and gum samples over time to see if the diet helped calm the body's response.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

28 people

The number who actually took part.

Started

Dec 2023

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-70 years * Periodontitis stages III-IV, generalized, grade C-B (according to the New World Workshop 2017) * Minimum of 20 teeth present: to ensure there are sufficient teeth for study and that the same teeth can be examined in all participants. * Systemically healthy participants (self-reported questionnaires will be used). * Body mass index: 18.5-30 kg/m2 (normal weight to overweight, but not obese) * Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form * Be willing and physically able to carry out all study procedures (e.g. multiple cycles of a 5-day dietary regimen and blood samples) * Absence of hopeless teeth, acute dental conditions, teeth with endodontic-periodontal lesions and necrotising periodontal diseases Exclusion Criteria: * Age \> 70 years. Exclusion for safety and feasibility reasons and to minimize the complicating factors such as frailty and un-/under-diagnosed medical conditions. * Less than 20 teeth present * Patients who received any periodontal treatment in the last 12 months * Smoking (defined as self-reported use of any cigarettes or electronic cigarettes for at least 5 years): to avoid the potential confounding effect of smoking * Mental illness, including severe depression, dementia. To ensure safety and compliance of the protocol * Drug dependency * Hormone replacement therapy (DHEA, estrogen, thyroid, testosterone). * Severe hypertension (systolic BP \> 200 mm Hg and/or diastolic BP \> 105 mm Hg) * Underweight (BMI \< 18.5 kg/m2) * Currently taking part in other clinical trials: to prevent either from interfering with the results of the other * Pregnant or breastfeeding women: to prevent hormonal changes from influencing the amount of inflammation * Taking medications including systemic anti-inflammatory medication within 3 months of the study (NSAIDs, no more than once per week and not in the week before sample collection, is permitted) * Systemic antibiotic intake within 3 months: to prevent their microbiome-modulating effects from impacting the inflammatory status. * Current orthodontic treatment: interferes with plaque control measures. * Alcoholism (alcohol intake greater than two drinks per day for women and three drinks per day for men) * Denture wearer/presence of dental implants: They may have an effect on periodontal parameters of neighbouring teeth * Obvious signs of untreated caries and other significant oral diseases which in the opinion of the Study Dentist will affect either the scientific validity of the study, or if the volunteer was to participate in the study would affect their wellbeing * Unable or unwilling to participate in baseline or follow-up examinations * Unable or unwilling to complete the dietary intervention * Special dietary requirements incompatible with the study interventions * Significant food allergies which would make the subject unable to consume the food provided

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Periodontal disease, avdc stage 3 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universida de Santiago de Compostela

    Santiago de Compostela, Spain

  • Universidad Complutense de Madrid

    Madrid, Spain

  • Universidad de Granada

    Granada, Spain

  • Universidad de Murcia

    Murcia, Spain

  • Universitat Internacional de Catalunya

    Sant Cugat del Vallès, Barcelona, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.